Chloe Atreya, MD, PhD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases (NCT03844750) | Chloe Atreya, MD, PhD | 2019-07-22 |
Track Chloe Atreya, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.